Novel solid lipid nanoparticle medicament delivery system for protein-loaded medicaments

A solid lipid nano and solid lipid technology, which is applied in drug delivery, liposome delivery, pharmaceutical formulations, etc., can solve the problems of severe preparation process conditions, poor stability of protein drugs, and low bioavailability, so as to reduce toxicity Effects of side effects, enhanced bioavailability, and enhanced therapeutic index

Active Publication Date: 2011-06-29
SICHUAN UNIV
View PDF4 Cites 30 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] Therefore, looking at the research of the whole protein solid lipid nanoparticle drug delivery system, although its prescription design and preparation technology are constantly improving, and can solve the defects of the existing technology from a certain aspect, it ignores other aspects. problems or the introduction of other new prob

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel solid lipid nanoparticle medicament delivery system for protein-loaded medicaments
  • Novel solid lipid nanoparticle medicament delivery system for protein-loaded medicaments
  • Novel solid lipid nanoparticle medicament delivery system for protein-loaded medicaments

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0078] Example 1 Examine the concentration of biological surface active agents to the packet and particle size inspection of nanoparticles:

[0079] Examine the amount of sodium gall acid S The effect of CT-SLNS preparation.Precision is called salmon decreased calcium ( S CT) 3.75mg is dissolved in 0.01mol / ml HCL aqueous solution of 0.5ml, adds an appropriate amount of sodium bile acid after dissolving, 30min, and then adds to dissolved 1 mg of 1mg of glycolic acid, 10mg of Palm acid glycolin, and 20mg of soybean phospholipids.In the 1ml dichloromethane solution.Probe ultrasound 15S and 40W of power, forming colostrum.Add colostrum to a 0.1%Polosam 188 solution of 4ml, the probe ultrasonic 15S and the power of 80W, forming nanomal milk.Dilute the nano -milk with the same concentration of Polosham 188, and then steam it to dichloromethane completely.

[0080] The amount of sodium gallopate is examined in accordance with the above preparation methods to 0, 10, 20, 30, 50, 100, 150m...

Embodiment 2

[0081] Example 2 Examine the types of organic solvents on the type of nanopartal particle size and stability:

[0082] Examine different organic solvents pairs S CT-SLNS has the effects of particle size and stability. It is precisely known as salmon reduced calcium calcium or 7.5mg to dissolve in 0.5ml 0.01mol / ml HCL aqueous solution.In the 1ml organic solvent of 20mg of phospholipid, the probe ultrasonic 15S and the power of 40W, forming colostrum.Add colostrum to a 0.1%Polosam 188 solution of 4ml, the probe ultrasonic 15S and the power of 80W, forming nanomal milk.Dilute nanocal milk with the same concentration of Polosam 188 solution and steam to the organic solvents completely, that is, the SCT-SLNS dispersing solution is obtained to check the changes in particle size and stability. Among them, the stability is 'good',The evaluation of ',' difference ',' / ', of which' good 'means that after 24 hours of placement, the particle size is not changed, and the solution is a clear ...

Embodiment 3

[0087] Example 3 The effect of examining different lipid materials on the packaging rate, particle size and stability:

[0088] Precision is called salmon oligomatin 7.5mg dissolved in 0.5ml 0.01mol / ml HCL aqueous solution, adds 25 mg of sodium sodium after dissolving, 30 minutes of vortex, and then adds to dissolved (according to SLN1, 2, 4-4 in Table 2The 10th prescription requires different ratios to add mixed lipid materials) 1ml dichloromethane solution for lipid materials.Probe ultrasound 15S and 40W of power, forming colostrum.Add colostrum to the Polosam 188 solution of 4ml0.1%, the probe ultrasonic 15S and the power of 80W, forming nanomal milk.Dilute the nano -milk with the same concentration of Polosham 188, and then steam it to dichloromethane completely.The effects of each prescription on the package rate, particle size and stability (stability after 24 hours) are shown in Table 2:

[0089] Table 2: Different lipid materials Mixed -packed and particle size inspection...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides novel solid lipid nanoparticles for protein medicaments and a preparation method thereof. Each solid lipid nanoparticle consists of two parts, namely a core and a shell, wherein the core is that a biosurfactant forms a micelle or an aggregate to wrap active ingredients, or/and the biosurfactant and the active ingredients form a synergic aggregate; and the shell is that a solid lipid material is adopted for encapsulating the core. A novel solid lipid nanoparticle medicament delivery system has extremely high safety, can effectively protect the biological activity of polypeptides and polypeptide medicaments and remarkably improve the stability of preparations of the polypeptides and the polypeptide medicaments at the same time, can be applied in multiple ways such as injection, non-injection and the like, and achieves better bioavailability.

Description

Technical field [0001] The invention involves a new type of medication system for protein, especially the solid lipid nanoprocryment system for new type of protein drugs, which belongs to the field of biopharmaceutical preparations. Background technique [0002] Protein drugs are widely used in the treatment of various major diseases, but due to some special properties of itself, it has a lot of restrictions in its application and cannot fully play a role.To this end, many scientific researchers have begun to study and develop stability in recent years, long half -life, good biocompatibility, and easy to absorb protein drugs. [0003] Solid Lipid Nanoparticle (SLN) is a targeted controlled gum supplier system that has been active in recent years after emulsion and lipids.It wraps drugs in a solid natural or synthetic lipids in a lipid -like solid gum gauge dosing system with a particle size of about 50 to 1000 nm. It usually presents solid state at room temperature.The advantag...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/127A61K9/14A61K9/12A61K9/19A61K9/72A61K47/28
Inventor 黄园陈春会樊婷婷张志荣
Owner SICHUAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap